Kayvan Mirhadi

Kayvan Mirhadi practices at Clifton Springs Hospital and Clinic in Clifton Springs, New York, part of Rochester Regional Health.

Kayvan Mirhadi's NPI, 1972928224, was assigned on February 24, 2014. Kayvan Mirhadi graduated from St. George's University School of Medicine in 2014. Kayvan Mirhadi holds New York license 290051.

Kayvan Mirhadi's primary practice is Clifton Springs Hospital and Clinic, at 2 Coulter Road, Clifton Springs, NY 14432 in Ontario County. The practice phone is (315) 462-9561.

Kayvan Mirhadi's primary practice is Clifton Springs Hospital and Clinic in Clifton Springs, New York, part of Rochester Regional Health. Kayvan Mirhadi is also affiliated with Rochester General Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Kayvan Mirhadi to 1 more hospital and 2 medical groups, each named with a free account. Kayvan Mirhadi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Kayvan Mirhadi practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Kayvan Mirhadi's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Kayvan Mirhadi is licensed in New York.

CMS data shows 479 Medicare services from Kayvan Mirhadi across 5 procedure codes in 2024, for 103 Medicare patients. Medicare paid $40,460 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 103 Medicare patients who saw Kayvan Mirhadi in 2024. The largest group is under 65, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kayvan Mirhadi's median patient age at 77, with 53% women.

In 2024, Kayvan Mirhadi wrote 294 Medicare Part D claims for 138 patients. 84% of them were for generic drugs. CMS names the drug for 84 of them, across 6 drugs with 11 or more claims each, at $12,806 in total drug cost. In 2023, CMS named 111 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Kayvan Mirhadi for performance year 2024, reported through an alternative payment model (APM). Kayvan Mirhadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Kayvan Mirhadi from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Inari Medical, Inc. paid the most, $107.

Kayvan Mirhadi graduated from St. George's University School of Medicine in 2014.